Provided by Tiger Trade Technology Pte. Ltd.

ImmunityBio, Inc.

7.06
+1.0417.31%
Volume:9.35M
Turnover:63.48M
Market Cap:6.96B
PE:-17.00
High:7.14
Open:6.06
Low:6.06
Close:6.02
52wk High:8.28
52wk Low:1.83
Shares:984.97M
Float Shares:194.00M
Volume Ratio:6.83
T/O Rate:4.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4153
EPS(LYR):-0.6189
ROE:78.05%
ROA:-36.89%
PB:-13.27
PE(LYR):-11.41

Loading ...

Feb 18, 2026

Major Issues Report

Form 8-K - Current report
Jan 26, 2026

Major Issues Report

Form 8-K - Current report
Jan 21, 2026

Proposed Sale Of Securities

Form 144 | IMMUNITYBIO's Director Christobel Selecky proposes to sell 25000 shares, with a total value of approximately $138,000.
Jan 20, 2026

Proposed Sale Of Securities

Form 144 | ImmunityBio's Officer and Director Simon Barry J. proposes to sell 571,967 Shares, with a total value of approximately $5.90 Million.
Jan 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2026

Major Issues Report

Form 8-K - Current report
Jan 14, 2026

Major Issues Report

Form 8-K - Current report
Dec 24, 2025

Major Issues Report

Form 8-K - Current report
Dec 16, 2025

Major Issues Report

Form 8-K - Current report
Dec 12, 2025

Major Issues Report

Form 8-K - Current report
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2025

Major Issues Report

Form 8-K - Current report
Aug 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2025

Major Issues Report

Form 8-K - Current report
Jul 25, 2025

Major Issues Report

Form 8-K - Current report
Jun 23, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 20, 2025

Major Issues Report

Form 8-K - Current report
May 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2025

Major Issues Report

Form 8-K - Current report